# Understanding Non-small Cell Lung Cancer Patient Characteristics, Treatment Patterns and Outcomes

> **NCT07215026** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 833 (actual)

## Conditions studied

- Non-small Cell Lung Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07215026
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2025-10-27
- **Primary completion:** 2026-01-21
- **Final completion:** 2026-01-21
- **Target enrollment:** 833 (ACTUAL)
- **Last updated:** 2026-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07215026

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07215026, "Understanding Non-small Cell Lung Cancer Patient Characteristics, Treatment Patterns and Outcomes". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT07215026. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*